French Study Confirms Teratogenic Risks Of Valproate; Other Drugs In The Spotlight Too

The risks of major congenital malformations in children born of women who took the anti-epileptic valproate have been confirmed by a new French study, which has also detected new risks with both old and more recent drugs for epilepsy and bipolar disorder.

French authorities have reported on birth defects with anti-epileptic drugs

More from Drug Safety

More from Pink Sheet